AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

enCore Energy Corp. (EU) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to convert net income into positive operating cash flow, highlighted by a $21.4 million operating cash outflow in 2026Q1, suggests significant execution risk in its production restart strategy.
enCore Energy Corp. (EU) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
enCore Energy Corp. (EU) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 14, 2026 | $0.09vs $0.06-50.0% | $18Mvs $15M+21.1% |
| Q2 2026 | Apr 1, 2026 | $0.09vs $0.05-76.6% | $17Mvs $12M+42.9% |
| Q2 2026 | Mar 9, 2026 | $0.09vs $0.05-76.6% | $12Mvs $12M+4.1% |
| Q4 2025 | Nov 10, 2025 | $0.07vs $0.10+28.6% | $9Mvs $15M-41.4% |
Recent stock market news and headlines for enCore Energy Corp. (EU)
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positi

Universal Music Group N.V. Reports Weekly Transactions under its â¬500 Million Share Buyback Program PR Newswire

NASDAQ: EUTSXV: EU www.encoreuranium.com DALLAS, June 22, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, announced today that the U.S. Nuclear Regulatory Commission ("NRC") issued an Environmental Assessment which was followed with a Finding of No Significant Impact in support of the Dewey Burdock Uranium Project's 20-year Source Materials License, currently in Timely Renewal status. With the Finding of No Significant Impact, the NRC has stated that it will renew the Dewey Burdock license if the NRC concludes that enCore, through its wholly-owned subsidiary Powertech USA, Inc., has demonstrated it will continue to meet NRC safety requirements for construction and operation of an In-Situ Recovery ("ISR") facility.

NASDAQ: EUTSXV: EU www.encoreuranium.com DALLAS, June 18, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced that the Bureau of Land Management ("BLM") has issued a final decision and approved the Dewey Burdock Uranium Project, authorizing the Company to commence infrastructure construction for the Dewey Burdock Uranium In-Situ Recovery (ISR) Project in Southwest South Dakota. With the execution of the final Environmental Assessment (EA) and Finding of No Significant Impact, the BLM authorizes enCore's wholly owned subsidiary Powertech Inc. to construct initial ancillary infrastructure on approximately 240 acres of BLM-managed public land within the larger 10,580-acre Dewey Burdock Project.

Key metrics vs top competitors for enCore Energy Corp. (EU)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.26 | $244.73M | -3.07 | 1.51% | -131.75% | -27.04% | — | |
| $9.90 | $4.9B | -49.50 | 29737.95% | -516.16% | -8.13% | — | |
| $1.29 | $512.56M | -6.45 | -19.28% | -297.95% | -105.1% | — | |
| $3.15 | $2.85B | -17.91 | 22.25% | -5909.07% | -65.41% | — | |
| $12.86 | $3.21B | -34.76 | -15.61% | -82.7% | -10.16% | — | |
| $94.67 | $41.22B | 99.66 | 10.95% | 16.93% | 8.76% | — |
enCore Energy Corp. (EU) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
enCore Energy Corp. (EU) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 14, 2026·SEC
Apr 20, 2026·SEC
Mar 9, 2026·SEC
Mar 31, 2026·SEC
May 14, 2026·SEC
Get notified when EU posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
enCore Energy Corp. (EU) stock FAQ — growth, dividends, profitability & financials explained
enCore Energy Corp. (EU) reported $43.2M in revenue for fiscal year 2025.
enCore Energy Corp. (EU) grew revenue by 1.5% over the past year. Growth has been modest.
enCore Energy Corp. (EU) reported a net loss of $27.2M for fiscal year 2025.
enCore Energy Corp. (EU) has a return on equity (ROE) of -27.0%. Negative ROE indicates the company is unprofitable.
enCore Energy Corp. (EU) had negative free cash flow of $56.7M in fiscal year 2025, likely due to heavy capital investments.